Meta-analysis of the IPF1 D76N polymorphism in a worldwide type 2 diabetes population

Minerva Medica

Volumn 98, Issue 3, 2007, Pages 163-166

  Gragnoli, C ^a,b,c,d   Cronsell, J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c Bios Biotech Multi Diagnostic Health Center   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Genetics; Insulin promoter factor 1; Meta analysis; Type 2 diabetes

Indexed keywords

ARTICLE; CLINICAL TRIAL; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INSULIN PROMOTER FACTOR 1 GENE; INSULIN RELEASE; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; SYSTEMATIC REVIEW;

ADULT; CHI-SQUARE DISTRIBUTION; DIABETES MELLITUS, TYPE 2; EUROPE; HETEROZYGOTE; HOMEODOMAIN PROTEINS; HUMANS; ITALY; ODDS RATIO; POLYMORPHISM, GENETIC; TRANS-ACTIVATORS; WORLD HEALTH;

EID: 34848887005     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Habener JF. The role of pancreatic duodenum homeobox protein-1 in the development of diabetes mellitus. Drug News Perspect 2002;15:491-7.
2. Hani EH, Stoffers DA, Chevre JC, Durand F, Stanojevic V, Habener JF et al. Defective mutations in the insulin promoter factor-1 gene (IPF-1) in late-onset type 2 diabetes mellitus. J Clin Invest 1999;104:R41-8.
3. Macfarlane WM, Frayling TM, Ellard S, Evans JC, Allen LI, Bulman MP et al. Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes. J Clin Invest 1999;104:R33-9.
4. Owen KR, Evans JC, Frayling TM, Hattersly AT, McCarthy MI, Walker M et al. Role of the D76N polymorphism of insulin promoter factor-1 in predisposing to Type 2 diabetes. Diabetologia 2004;47:957-8.
5. Elbein SC, Karim MA. Does the aspartic acid to asparagine substitution at position 76 in the pancreas duodenum homeobox gene (PDX1) cause late-onset type 2 diabetes? Diabetes Care 2004;27:1968-73.
6. Reis AF, Ye WZ, Dubois-Laforgue D, Bellanne-Chantelot C, Timsit J, Velho G. Mutations in the insulin promoter factor-1 gene in late-onset type 2 diabetes mellitus. Eur J Endocrinol 2000;143:511-3.
7. Hansen L, Urioste S, Petersen HV, Jensen JN, Eiberg H, Barbetti F et al. Missense mutations in the human insulin promoter factor-1 gene and their relation to maturity-onset diabetes of the young and late-onset type 2 diabetes mellitus in Caucasians. J Clin Endocrinol Metab 2000;85:1323-6.
8. Weng J, MacFarlane WM, Lehto M, Gu HF, Shepherd LM, Ivarsson SA et al. Functional consequences of mutations in the MODY4 gene (IPF1) and coexistence with MODY3 mutations. Diabetologia 2001;44:249-58.
9. Silver K, Shetty A. IPF-1 gene variation and the development of type 2 diabetes. Mol Genet Metab 2002;75:287-9.
10. Cockburn BN, Bermano G, Boodram LL, Teelucksingh S, Tsuchiya T, Mahabir D et al. Insulin promoter factor-1 mutations and diabetes in Trinidad: identification of a novel diabetes-associated mutation (E224K) in an Indo-Trinidadian family. J Clin Endocrinol Metab 2004;89:971-8.
11. Inoue H, Riggs AC, Tanizawa Y, Ueda K. Isolation, characterization, and chromosomal mapping of the human insulin promoter factor 1 (IPF-1) gene. Diabetes 1996;45:789-94.
12. Yasuda K, Okada T, Sunaga Y, Kajimoto Y, Shibasaki T, Kaburagi Y et al. Identification of early-onset diabetes due to a frame-shift mutation in Ipf-1 gene in Japanese. European Association for the Study of Diabetes (EASD) 2004, September 5-9, Munich.
13. Hara M, Lindner TH, Paz VP, Wang X, Iwasaki N, Ogata M et al. Mutations in the coding region of the insulin promoter factor 1 gene are not a common cause of maturity-onset diabetes of the young in Japanese subjects. Diabetes 1998;47:845-6.
14. Shiau MY, Huang CN, Liao JH, Chang YH. Missense mutations in the human insulin promoter factor-1 gene are not a common cause of type 2 diabetes mellitus in Taiwan. J Endocrinol Invest 2004;27:1076-80.
15. Gragnoli C, Stanojevic V, Gorini A, Von Preussenthal GM, Thomas MK, Habener JF. IPF-1/MODY4 gene missense mutation in an Italian family with type 2 and gestational diabetes. Metabolism 2005;54:983-8.